RFP Financial Group’s AbbVie ABBV Stock Holding History

RFP Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-506	Closed	-$86.8K	–	107
2024 Q2	$86.8K	Sell	506 -41	-7%	-$6.79K	0.03%	175
2024 Q1	$99.6K	Sell	547 -373	-41%	-$64.3K	0.04%	145
2023 Q4	$143K	Buy	920 +93	+11%	+$13.6K	0.06%	113
2023 Q3	$123K	Hold	827	–	–	0.05%	116
2023 Q2	$111K	Buy	827 +466	+129%	+$68.3K	0.05%	139
2023 Q1	$57.5K	Sell	361 -400	-53%	-$61.2K	0.07%	105
2022 Q4	$123K	Buy	+761	New	+$117K	0.06%	123

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

RFP Financial Group's ABBV Position: Q3 2024 in Review

RFP Financial Group sold out of AbbVie (ABBV) in Q3 2024, closing a stake of 506 shares — an estimated $86.8K sold.

RFP Financial Group first reported a position in ABBV in Q4 2022 and held it in 7 quarters. The position peaked at $143K in Q4 2023. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

RFP Financial Group reported no remaining AbbVie position as of Q3 2024 after selling out during the quarter.
RFP Financial Group sold 506 AbbVie shares in Q3 2024, an estimated $86.8K.
RFP Financial Group first reported a position in AbbVie in Q4 2022 and held it in 7 quarters.
RFP Financial Group's AbbVie position peaked at $143K in Q4 2023.
3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.